Eli Lilly to pay more than $800 million for off-label promotion of Zyprexa
January 20th 2009Eli Lilly and Co. has agreed to plead guilty to one misdemeanor violation of the Food, Drug, and Cosmetic Act and will pay more approximately $800 million for unproven marketing and promotional claims involving the antipsychotic medication Zyprexa.
Sizzling sun care category led by technology and consumer needs
January 7th 2009Sun care is a hot category that continues to grow. Regardless of seasonality in most parts of the country and many years of flat sales, this category has come back strong in the last few years thanks to new technology, specialized products, and an overall greater consumer awareness of the sun's dangerous effects.
IV drug errors highlight need for universal standards
January 1st 2009The annual summit of the American Society of Health-System Pharmacists called for ways to reduce drug errors. The need for universal IV concentrations is primary. "Safety will improve dramatically if we all work with the same tools." (Peter Angood, Joint Commission)
UCSF investigators: Drug companies distort trial information
December 17th 2008A team of medical investigators at the University of California, San Francisco, has accused drug companies of bias by distorting the results of their trials in medical journals, which many doctors rely on to determine whether to prescribe new drugs.
JUPITER: Rosuvastatin reduces events in patients without hyperlipidemia but with elevated hsCRP
November 10th 2008Rosuvastatin treatment of patients with better than average lipid profiles but with elevated high-sensitivity C-reactive protein (hsCRP) resulted in a 44% relative risk reduction in cardiovascular events and a 20% reduction in all-cause mortality, reports Paul Ridker, MD (pictured), lead investigator for the JUPITER Trial Study Group. JUPITER was an investigator-initiated trial sponsored by AstraZeneca.
Hospital-acquired diabetic complications: How pharmacists can help prevent them
November 10th 2008Medicare has stopped paying hospitals for blood conditions caused by poor inpatient glycemic control. Health-system pharmacists can help prevent these conditions and reduce uncompensated expenses by insisting on proper protocols.
Anticoagulant safety practices call for pharmacist supervision
November 10th 2008The Joint Commission's anticoagulant safety goal goes into effect Jan. 1, 2009. Physicians, pharmacists, and nurses at health-care systems around the country are collaborating to improve best practices and to put more stringent measures in place.
Smart pump technology reduces errors and saves lives
October 13th 2008Hospitals throughout California are embracing smart pump technology as a way to reduce error and save lives. Among them are The Little Company of Mary (Torrance), Torrance Memorial Medical Center, and the Kaiser Permanente South Bay Medical Center in Harbor City.